Qiagen and Illumina just made a huge commitment to one another. The two companies announced a 15-year partnership to broaden the availability and use of NGS-based in-vitro diagnostic kits, including companion diagnostics, for patient management.
Initially, the partnership will focus on commercializing oncology IVD kits to support patient management.
The agreement grants Hilden, Germany-based Qiagen non-exclusive rights to develop and globally commercialize IVD kits to be used together with Illumina’s MiSeq Dx and NextSeq 550Dx Systems.
{iframe}https://www.mddionline.com/qiagen-and-illumina-it-long-haul-15-year-collaboration{/iframe}